Sahlas DJ - Search Results

1

Methods for Improving Screening for Vascular Cognitive Impairment Using the Montreal Cognitive Assessment.

Zaidi KB, Rich JB, Sunderland KM, Binns MA, Truong L, McLaughlin PM, Pugh B, Kwan D, Beaton D, Levine B, Sahlas DJ, Dowlatshahi D, Hassan A, Mandzia J; ONDRI Investigators; Troyer AK, Swartz RH. Zaidi KB, et al. Among authors: sahlas dj. Can J Neurol Sci. 2020 Nov;47(6):756-763. doi: 10.1017/cjn.2020.121. Epub 2020 Jun 11. Can J Neurol Sci. 2020. PMID: 32522309

2

Prevalence of "Ghost Infarct Core" after Endovascular Thrombectomy.

Ospel JM, Rex N, Rinkel L, Kashani N, Buck B, Rempel J, Sahlas D, Kelly ME, Budzik R, Tymianski M, Hill MD, Goyal M; ESCAPE-NA1 Investigators. Ospel JM, et al. AJNR Am J Neuroradiol. 2024 Mar 7;45(3):291-295. doi: 10.3174/ajnr.A8113. AJNR Am J Neuroradiol. 2024. PMID: 38272571

3

Clasmatodendrosis correlating with periventricular hyperintensity in mixed dementia.

Sahlas DJ, Bilbao JM, Swartz RH, Black SE. Sahlas DJ, et al. Ann Neurol. 2002 Sep;52(3):378-81. doi: 10.1002/ana.10310. Ann Neurol. 2002. PMID: 12205656

4

A new visual rating scale to assess strategic white matter hyperintensities within cholinergic pathways in dementia.

Bocti C, Swartz RH, Gao FQ, Sahlas DJ, Behl P, Black SE. Bocti C, et al. Among authors: sahlas dj. Stroke. 2005 Oct;36(10):2126-31. doi: 10.1161/01.STR.0000183615.07936.b6. Epub 2005 Sep 22. Stroke. 2005. PMID: 16179569

5

Strategic subcortical hyperintensities in cholinergic pathways and executive function decline in treated Alzheimer patients.

Behl P, Bocti C, Swartz RH, Gao F, Sahlas DJ, Lanctot KL, Streiner DL, Black SE. Behl P, et al. Among authors: sahlas dj. Arch Neurol. 2007 Feb;64(2):266-72. doi: 10.1001/archneur.64.2.266. Arch Neurol. 2007. PMID: 17296844 Clinical Trial.

6

Strategic involvement of cholinergic pathways and executive dysfunction: Does location of white matter signal hyperintensities matter?

Swartz RH, Sahlas DJ, Black SE. Swartz RH, et al. Among authors: sahlas dj. J Stroke Cerebrovasc Dis. 2003 Jan;12(1):29-36. doi: 10.1053/jscd.2003.5. J Stroke Cerebrovasc Dis. 2003. PMID: 17903901

7

Inflammatory cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease.

Bui E, Ehrensperger E, Sahlas DJ, Murray BJ, Bergeron C, Glikstein RS, Aviv R, Schipper HM. Bui E, et al. Among authors: sahlas dj. Can J Neurol Sci. 2008 Nov;35(5):625-9. doi: 10.1017/s0317167100009422. Can J Neurol Sci. 2008. PMID: 19235447

8

Tissue plasminogen activator overdose in acute ischemic stroke patients linked to poorer functional outcomes.

Sahlas DJ, Gould L, Swartz RH, Mohammed N, McNicoll-Whiteman R, Naufal F, Oczkowski W. Sahlas DJ, et al. J Stroke Cerebrovasc Dis. 2014 Jan;23(1):155-9. doi: 10.1016/j.jstrokecerebrovasdis.2013.01.004. Epub 2013 Jan 31. J Stroke Cerebrovasc Dis. 2014. PMID: 23375748

9

Screening for cognitive impairment in a stroke prevention clinic using the MoCA.

Mai LM, Oczkowski W, Mackenzie G, Shuster A, Wasielesky L, Franchetto A, Patlas M, Sahlas DJ. Mai LM, et al. Among authors: sahlas dj. Can J Neurol Sci. 2013 Mar;40(2):192-7. doi: 10.1017/s031716710001372x. Can J Neurol Sci. 2013. PMID: 23419567

10

Response to "Effect of tissue plasminogen activator dose and interval on stroke severity".

Sahlas DJ, Gould L, Swartz R, Mohammed N, McNicoll-Whiteman R, Naufal F, Oczkowski W. Sahlas DJ, et al. J Stroke Cerebrovasc Dis. 2014 Jan;23(1):198. doi: 10.1016/j.jstrokecerebrovasdis.2013.10.027. Epub 2013 Dec 2. J Stroke Cerebrovasc Dis. 2014. PMID: 24291015 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters